Ketogenic diet shows promise in treating anxiety, depression, and other mental health disorders, study finds
Can't see this email? View it online
   
  Schizophrenia Schizophrenia logo  
  The latest schizophrenia news from News Medical  
 Ketogenic diet improves metabolic and mental health in schizophrenia and bipolar disorder patients, study findsKetogenic diet improves metabolic and mental health in schizophrenia and bipolar disorder patients, study finds
 
Researchers found that a ketogenic diet significantly improves both metabolic and psychiatric health in individuals with schizophrenia or bipolar disorder, with notable reductions in weight, waist circumference, and mental illness severity.
 
 
 Ketogenic diet shows promise in treating anxiety, depression, and other mental health disorders, study findsKetogenic diet shows promise in treating anxiety, depression, and other mental health disorders, study finds
 
Research suggests the ketogenic diet may offer benefits in managing anxiety, depression, stress, schizophrenia, and bipolar disorder, but more clinical trials are needed to confirm its efficacy.
 
   Ancient viral sequences in the human genome may contribute to psychiatric disorder susceptibilityAncient viral sequences in the human genome may contribute to psychiatric disorder susceptibility
 
New research led by King's College London has found that thousands of DNA sequences originating from ancient viral infections are expressed in the brain, with some contributing to susceptibility for psychiatric disorders such as schizophrenia, bipolar disorder, and depression.
 
   Study may facilitate the development of new personalized treatments for schizophrenia                                                       An International Study Publi...Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi...
 
An international study led by the Hospital del Mar Medical Research Institute, in collaboration with researchers from the Neuropsychopharmacology Group at the University of the Basque Country (UPV/EHU) and researchers from the CIBER of Mental Health (CIBERSAM), and published in Nature Communications, may facilitate the creation of new personalized treatments for people diagnosed with schizophrenia.
 
   Study sheds new light on the intricate molecular mechanisms underlying schizophreniaStudy sheds new light on the intricate molecular mechanisms underlying schizophrenia
 
Schizophrenia is a complex disease with variable presentations, and the diverse nature of this mental health disorder has made understanding the mechanisms that cause the disease, and subsequently developing effective treatments, especially challenging.
 
 Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease
 
Comprehensive study provides new understandings of genomic influences on neuropsychiatric diseaseA new analysis has revealed detailed information about genetic variation in brain cells that could open new avenues for the targeted treatment of diseases such as schizophrenia and Alzheimer's disease.
 
 
 Two new studies offer insights into the molecular biology of neuropsychiatric disease
 
Two new studies offer insights into the molecular biology of neuropsychiatric diseaseWorking under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular biology of neuropsychiatric disease through two new studies published in a special issue of Science on Friday, May 24.
 
 
 GSA-MiXeR: A powerful tool to improve our understanding of heritable traits and diseases
 
GSA-MiXeR: A powerful tool to improve our understanding of heritable traits and diseasesResearchers from the University of Oslo have developed an innovative tool that promises to improve our understanding of heritable human traits and diseases.